218
Views
69
CrossRef citations to date
0
Altmetric
Review Article

Provision of cardiovascular protection by ACE inhibitors:a review of recent trials

Pages 1559-1569 | Accepted 11 Aug 2004, Published online: 19 Sep 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Claudio Borghi, Stefano Omboni, Giorgio Reggiardo, Stefano Bacchelli, Daniela Degli Esposti & Ettore Ambrosioni. (2017) Cardioprotective role of zofenopril in hypertensive patients with acute myocardial infarction: a pooled individual data analysis of the SMILE studies. Blood Pressure 26:4, pages 211-219.
Read now
M. S. Christiansen, K. Iversen, C. T. Larsen, J. P. Goetze, E. Hommel, J. Mølvig, B. K. Pedersen, E. Magid & B. Feldt‐Rasmussen. (2009) Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes. Scandinavian Journal of Clinical and Laboratory Investigation 69:2, pages 272-281.
Read now
Elwira Telejko. (2007) Perindopril arginine: benefits of a new salt of the ACE inhibitor perindopril. Current Medical Research and Opinion 23:5, pages 953-960.
Read now
Hendrik Buikema. (2006) Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease. Expert Review of Cardiovascular Therapy 4:5, pages 631-647.
Read now
. (2006) Medifile drug Information bulletin. South African Family Practice 48:4, pages 60-64.
Read now
Sheila A Doggrell. (2006) Is amlodipine the best initial monotherapy for hypertension?. Expert Opinion on Pharmacotherapy 7:6, pages 829-832.
Read now
Xiaoguang Zhu, Rongyan Zhang, Nicholas F. Campagna & Ming Zhao. (2006) Assessment of Reperfused Myocardial Infarction in the Hyper-Acute Phase with Delayed Enhancement Magnetic Resonance Imaging. Journal of Cardiovascular Magnetic Resonance 8:3, pages 461-467.
Read now

Articles from other publishers (62)

Jingjing Xu, Xiaohua Jiang & Suowen Xu. (2023) Aprocitentan, a dual endothelin-1 (ET-1) antagonist for treating resistant hypertension: Mechanism of action and therapeutic potential. Drug Discovery Today 28:11, pages 103788.
Crossref
Jing Yang, Hongxia Li, Chi Zhang & Yafeng Zhou. (2022) Indoxyl sulfate reduces Ito,f by activating ROS/MAPK and NF-κB signaling pathways. JCI Insight 7:3.
Crossref
Praveen K. Bayannavar, Ravindra R. Kamble, Shrinivas D. Joshi, Aravind R. Nesaragi, Saba Kauser J. Shaikh, Belgur S. Sudha, Suneel S. Dodamani & Swati R. Hoolageri. (2022) Design and Synthesis of Angiotensin Converting Enzyme (ACE) Inhibitors: Analysis of the Role of Tetrazole Ring Appended to Biphenyl Moiety. ChemistrySelect 7:2.
Crossref
O. A. Osipova, E. V. Gosteva, O. N. Belousova, T. P. Golivets, J. Yu. Chefranova, Yu. A. Lykov, A. N. Khachaturov & N. I. Golovina. (2021) Effect of angiotensin II receptor blocker therapy on markers of fibrosis and immune inflammation in hypertensive patients with chronic kidney disease after ischemic stroke. Cardiovascular Therapy and Prevention 20:7, pages 3078.
Crossref
Yongchang Su, Shicheng Chen, Shuilin Cai, Shuji Liu, Nan Pan, Jie Su, Kun Qiao, Min Xu, Bei Chen, Suping Yang & Zhiyu Liu. (2021) A Novel Angiotensin-I-Converting Enzyme (ACE) Inhibitory Peptide from Takifugu flavidus. Marine Drugs 19:12, pages 651.
Crossref
Nour K. Younis, Joseph A. Ghoubaira, Emmanuel P. Bassil, Houda N. Tantawi & Ali H. Eid. (2021) Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases. Nanomedicine: Nanotechnology, Biology and Medicine 36, pages 102433.
Crossref
Carla Borg Caruana, Sarah M. Jackson, Jacqueline Ngyuen Khuong, Ryan Campbell, Zhengyang Liu, Dhruvesh M. Ramson, Ned Douglas, Juliana Kok, Luke A. Perry & Jahan C. Penny-Dimri. (2020) Systematic review and meta-analysis of postoperative troponin as a predictor of mortality and major adverse cardiac events after vascular surgery. Journal of Vascular Surgery 72:3, pages 1132-1143.e1.
Crossref
J. Shim, W.-J. Song & A.H. Morice. (2020) Drug-Induced Cough. Physiological Research, pages S81-S92.
Crossref
Bharath Chelluboina & Raghu Vemuganti. (2019) Chronic kidney disease in the pathogenesis of acute ischemic stroke. Journal of Cerebral Blood Flow & Metabolism 39:10, pages 1893-1905.
Crossref
Kristien Daenen, Asmin Andries, Djalila Mekahli, Ann Van Schepdael, François Jouret & Bert Bammens. (2018) Oxidative stress in chronic kidney disease. Pediatric Nephrology 34:6, pages 975-991.
Crossref
Ran Su, Zhun Hou, Lihong Sang, Zhi-ming Zhou, Hao Fang & Xinying Yang. (2017) Enantioseparation of angiotensin II receptor type 1 blockers: evaluation of 6-substituted carbamoyl benzimidazoles on immobilized polysaccharide-based chiral stationary phases. Unusual temperature behavior. Journal of Chromatography A.
Crossref
Katya MokretarHristo VelinovArman PostadzhiyanMargarita Apostolova. (2016) Association of Polymorphisms in Endothelial Nitric Oxide Synthesis and Renin–Angiotensin–Aldosterone System with Developing of Coronary Artery Disease in Bulgarian Patients. Genetic Testing and Molecular Biomarkers 20:2, pages 67-73.
Crossref
Ji Yeon Hyun, Hyun-Ju Kim, Mi-Ri Gwon, Hae Won Lee, Sook Jin Seong & Young-Ran Yoon. (2015) Fully Validated Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Fimasartan in Human Plasma. Analytical Sciences 31:12, pages 1335-1339.
Crossref
Xiao-Feng Han, Xing He, Miao Wang, Di Xu, Li-Ping Hao, Ai-Hua Liang, Jun Zhang & Zhi-Ming Zhou. (2015) Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center. European Journal of Medicinal Chemistry 103, pages 473-487.
Crossref
J. Ruth Wu-Wong, Yung-wu Chen & Jerry L. Wessale. (2015) Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats. American Journal of Physiology-Renal Physiology 308:4, pages F309-F319.
Crossref
Dena Dorniani, Mohd Hussein, Aminu Kura, Sharida Fakurazi, Abdul Shaari & Zalinah Ahmad. (2013) Sustained Release of Prindopril Erbumine from Its Chitosan-Coated Magnetic Nanoparticles for Biomedical Applications. International Journal of Molecular Sciences 14:12, pages 23639-23653.
Crossref
K. -K. Lau, Y. -H. Chan, Y. -K. Wong, K. -C. Teo, K. -H. Yiu, S. Liu, L. S. -W. Li, X. -O. Shu, S. -L. Ho, K. H. Chan, C. -W. Siu & Hung Fat Tse. (2013) Garlic intake is an independent predictor of endothelial function in patients with ischemic stroke. The journal of nutrition, health & aging 17:7, pages 600-604.
Crossref
M. Remko, J. Bojarska, P. Ježko, W. Maniukiewicz & A. Olczak. (2013) Molecular structure of antihypertensive drug perindopril, its active metabolite perindoprilat and impurity F. Journal of Molecular Structure 1036, pages 292-297.
Crossref
Hong Wang, Yue-Jin Yang, Hai-Yan Qian, Qian Zhang, Hui Xu & Jian-Jun Li. (2011) Resveratrol in cardiovascular disease: what is known from current research?. Heart Failure Reviews 17:3, pages 437-448.
Crossref
Abhishek S. Chitnis, Rajender R. Aparasu, Hua Chen & Michael L. Johnson. (2012) Effect of certain angiotensin-converting enzyme inhibitors on mortality in heart failure: A multiple-propensity analysis. Research in Social and Administrative Pharmacy 8:2, pages 145-156.
Crossref
Zain Ahmed & W. H. Wilson Tang. (2012) Pharmacologic Strategies to Target Oxidative Stress in Heart Failure. Current Heart Failure Reports 9:1, pages 14-22.
Crossref
Nicholas L. M. Cruden, Ninian N. Lang, Thomas J. MacGillivray, Neal G. Uren, Keith A. A. Fox & David E. Newby. (2011) Vasomotor and fibrinolytic responses to kinin receptor agonists in the atherosclerotic human lower limb. Heart and Vessels 27:2, pages 179-185.
Crossref
Sandra Palus, Robert Schur, Yoshihiro J. Akashi, Barbara Bockmeyer, Rakesh Datta, Heather Halem, Jesse Dong, Michael D. Culler, Volker Adams, Stefan D. Anker & Jochen Springer. (2011) Ghrelin and Its Analogues, BIM-28131 and BIM-28125, Improve Body Weight and Regulate the Expression of MuRF-1 and MAFbx in a Rat Heart Failure Model. PLoS ONE 6:11, pages e26865.
Crossref
Shu-Huai Tsai, Travis W. Hein, Lih Kuo & Vivian C. Yang. (2011) High glucose impairs EDHF-mediated dilation of coronary arterioles via reduced cytochrome P450 activity. Microvascular Research 82:3, pages 356-363.
Crossref
Iryna Voloshyna & Allison B. Reiss. (2011) The ABC transporters in lipid flux and atherosclerosis. Progress in Lipid Research 50:3, pages 213-224.
Crossref
Agustin Casimiro-Garcia, Gary F. Filzen, Declan Flynn, Christopher F. Bigge, Jing Chen, Jo Ann Davis, Danette A. Dudley, Jeremy J. Edmunds, Nadia Esmaeil, Andrew Geyer, Ronald J. Heemstra, Mehran Jalaie, Jeffrey F. Ohren, Robert Ostroski, Teresa Ellis, Robert P. Schaum & Chad Stoner. (2011) Discovery of a Series of Imidazo[4,5- b ]pyridines with Dual Activity at Angiotensin II Type 1 Receptor and Peroxisome Proliferator-Activated Receptor-γ . Journal of Medicinal Chemistry 54:12, pages 4219-4233.
Crossref
M. Remko, J. Bojarska, P. Ježko, L. Sieroń, A. Olczak & W. Maniukiewicz. (2011) Crystal and molecular structure of perindopril erbumine salt. Journal of Molecular Structure 997:1-3, pages 103-109.
Crossref
Adam S. GreensteinRaghupathy ParanthamanAlistair BurnsAlan JacksonRayaz A. MalikRobert C. BaldwinAnthony M. Heagerty. (2010) Cerebrovascular Damage in Late-Life Depression Is Associated With Structural and Functional Abnormalities of Subcutaneous Small Arteries. Hypertension 56:4, pages 734-740.
Crossref
Raghupathy Paranthaman, Adam S. Greenstein, Alistair S. Burns, J. Kennedy Cruickshank, Anthony M. Heagerty, Alan Jackson, Rayaz A. Malik, Marietta L.J. Scott & Robert C. Baldwin. (2010) Vascular Function in Older Adults with Depressive Disorder. Biological Psychiatry 68:2, pages 133-139.
Crossref
Y. Yamamoto, T. Yamashita, F. Kitagawa, K. Sakamoto, J.C. Giddings & J. Yamamoto. (2010) The effect of the long term aspirin administration on the progress of atherosclerosis in apoE-/- LDLR-/- double knockout mouse. Thrombosis Research 125:3, pages 246-252.
Crossref
Ronen Durst, Kobi Goldstein, Yuval Horowitz, Aaron Baggish, Meir Gare, Yonathan Hasin, Chaim Lotan & Michal Horowitz. (2010) Hypothyroid dependent myocardial angiotensin receptor trafficking is involved in improved cardiac performance after heat acclimation. Life Sciences 86:9-10, pages 331-336.
Crossref
Dimitris P. PapadopoulosVasilios PapademetriouThomas K. Makris. (2009) On Target to Dual Block RAS?. Angiology 60:6, pages 739-749.
Crossref
Lawrence A. Notaro, Mohammed H. Usman, James F. Burke, Aqeel Siddiqui, Keith R. Superdock & Michael D. Ezekowitz. (2009) Secondary Prevention in Concurrent Coronary Artery, Cerebrovascular, and Chronic Kidney Disease: Focus on Pharmacological Therapy. Cardiovascular Therapeutics 27:3, pages 199-215.
Crossref
Pawan D. Patel, Jose L. Velazquez & Rohit R. Arora. (2009) Endothelial dysfunction in African-Americans. International Journal of Cardiology 132:2, pages 157-172.
Crossref
Adil El MidaouiMahmoud Ali IsmaelHuogen LuI. George FantusJacques de ChamplainRéjean Couture. (2008) Comparative effects of N -acetyl- l -cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats . Canadian Journal of Physiology and Pharmacology 86:11, pages 752-760.
Crossref
Ilka Knütter, Claudia Wollesky, Gabor Kottra, Martin G. Hahn, Wiebke Fischer, Katja Zebisch, Reinhard H. H. Neubert, Hannelore Daniel & Matthias Brandsch. (2008) Transport of Angiotensin-Converting Enzyme Inhibitors by H + /Peptide Transporters Revisited . Journal of Pharmacology and Experimental Therapeutics 327:2, pages 432-441.
Crossref
J. Richard JenningsMatthew F. MuldoonJulie PriceIsrael C. ChristieCarolyn C. Meltzer. (2008) Cerebrovascular Support for Cognitive Processing in Hypertensive Patients Is Altered by Blood Pressure Treatment. Hypertension 52:1, pages 65-71.
Crossref
Mahmoud Ali Ismael, Sébastien Talbot, Cynthia L. Carbonneau, Christian M. Beauséjour & Réjean Couture. (2008) Blockade of sensory abnormalities and kinin B1 receptor expression by N-Acetyl-l-Cysteine and ramipril in a rat model of insulin resistance. European Journal of Pharmacology 589:1-3, pages 66-72.
Crossref
Ahmed ZaiemFaiez Zannad. (2008) Perindopril: beyond lowering blood pressure. Future Cardiology 4:3, pages 219-235.
Crossref
Matthew R. Weir & George L. Bakris. (2008) Combination Therapy With Renin-Angiotensin-Aldosterone Receptor Blockers for Hypertension: How Far Have We Come?. The Journal of Clinical Hypertension 10:2, pages 146-152.
Crossref
Ruey-Yun Wang, Chia-Min Chung, Cathy S.J. Fann, Hsin-Chou Yang, Jaw-Wen Chen, Yuh-Shiun Jong, Yuh-Shan Jou, Huey-Ming Lo, Feng-Ming Ho, Chih-Sen Kang, Chien-Chung Chen, Huan-Cheng Chang, Song-Kun Shyue & Wen-Harn Pan. (2008) Genome-Wide Scan for Quantitative ACE Activity in Taiwan Young-Onset Hypertension Study. Human Heredity 65:2, pages 85-90.
Crossref
Doris A. Taylor & Andrey G. Zenovich. 2008. Principles of Regenerative Medicine. Principles of Regenerative Medicine 812 851 .
C. Ceconi, G. Francolini, D. Bastianon, G.L. Gitti, L. Comini & R. Ferrari. (2007) Differences in the Effect of Angiotensin-converting Enzyme Inhibitors on the Rate of Endothelial Cell Apoptosis: In Vitro and In Vivo Studies. Cardiovascular Drugs and Therapy 21:6, pages 423-429.
Crossref
Kathleen M. ColleranAllyson RichardsKeri Shafer. (2023) Disparities in Cardiovascular Disease Risk and Treatment. Journal of Investigative Medicine 55:8, pages 415-422.
Crossref
Claudio Ceconi, Gloria Francolini, Adriana Olivares, Laura Comini, Tiziana Bachetti & Roberto Ferrari. (2007) Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. European Journal of Pharmacology 577:1-3, pages 1-6.
Crossref
M. Remko. (2007) Acidity, lipophilicity, solubility, absorption, and polar surface area of some ACE inhibitors. Chemical Papers 61:2.
Crossref
Adrian J B Brady. (2007) Perindopril versus Angiotensin II Receptor Blockade in Hypertension and Coronary Artery Disease. Clinical Drug Investigation 27:3, pages 149-161.
Crossref
Oon C. Ooi, Charles J. Mullany & Charanjit S. Rihal. 2007. Cardiovascular Therapeutics. Cardiovascular Therapeutics 157 177 .
A. G. Zenovich, B. H. Davis & D. A. Taylor. 2007. Bone Marrow-Derived Progenitors. Bone Marrow-Derived Progenitors 117 165 .
H. Morawietz, S. Rohrbach, U. Rueckschloss, E. Schellenberger, K. Hakim, H.-R. Zerkowski, G. Kojda, D. Darmer & J. Holtz. (2006) Increased cardiac endothelial nitric oxide synthase expression in patients taking angiotensin-converting enzyme inhibitor therapy. European Journal of Clinical Investigation 36:10, pages 705-712.
Crossref
Jun Tao, Chang Tu, Zhen Yang, Yan Zhang, Xiao-Lin Chung, Hong Ma & Zhen-Sheng Zhen. (2006) Enhanced external counterpulsation improves endothelium-dependent vasorelaxation in the carotid arteries of hypercholesterolemic pigs. International Journal of Cardiology 112:3, pages 269-274.
Crossref
Putul Sarkar, Grainne Nicholson & George Hall. (2006) Brief review: Angiotensin converting enzyme inhibitors and angioedema: anesthetic implicationsRevue sommaire sur les implications anesthésiques de l’œdème de Quincke et des inhibiteurs de l’enzyme de conversion de l’ngiotensine. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 53:10, pages 994-1003.
Crossref
Cíntia M. Melo, Aristóteles C. Alencar Filho, Tais Tinucci, Décio Mion & Cláudia L.M. Forjaz. (2006) Postexercise hypotension induced by low-intensity resistance exercise in hypertensive women receiving captopril. Blood Pressure Monitoring 11:4, pages 183-189.
Crossref
Armando Rojas, Hector Figueroa, Lamberto Re & Miguel A. Morales. (2006) Oxidative Stress at the Vascular Wall. Mechanistic and Pharmacological Aspects. Archives of Medical Research 37:4, pages 436-448.
Crossref
Philippe Meurin. (2006) The ASCOT Trial. American Journal of Cardiovascular Drugs 6:5, pages 327-334.
Crossref
Monique P Curran, Paul L McCormack & Dene Simpson. (2006) Perindopril. Drugs 66:2, pages 235-255.
Crossref
Karol Kramkowski, Andrzej Mogielnicki, Ewa Chabielska, Dorota Cylwik & Włodzimierz Buczko. (2006) The effect of ‘tissue’ and ‘plasma’ angiotensin converting enzyme inhibitors on overall haemostatic potentials in rats. Thrombosis Research 117:5, pages 557-561.
Crossref
Harjot K. Saini, Yan-Jun Xu, Amarjit S. Arneja, Paramjit S. Tappia & Naranjan S. Dhalla. (2005) Pharmacological basis of different targets for the treatment of atherosclerosis. Journal of Cellular and Molecular Medicine 9:4, pages 818-839.
Crossref
Young Lan Kwak. (2005) Reduction of Ischemia During Off-Pump Coronary Artery Bypass Graft Surgery. Journal of Cardiothoracic and Vascular Anesthesia 19:5, pages 667-677.
Crossref
Ryszard J. Gryglewski. (2005) Pharmacology of vascular endothelium. The FEBS Journal 272:12, pages 2956-2967.
Crossref
Rosemarie A Reiter & Bernd Jilma. (2005) Platelets and new antiplatelet drugs. Therapy 2:3, pages 465-502.
Crossref
Arduino A Mangoni. (2005) Cardiovascular Drug Therapy in Elderly Patients. Drugs & Aging 22:11, pages 913-941.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.